CD30 Antibody (Immunohistochemistry)

CD30 Antibody (Immunohistochemistry)

The CD30 Antibody is an important immunohistochemical marker used for detecting Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL).
CD30 is a transmembrane receptor of the TNF receptor family, expressed by Reed-Sternberg cells in classical Hodgkin lymphoma and in most cases of ALCL.

It also shows positive staining in Primary Cutaneous CD30+ T-cell Lymphoproliferative Disorders and Embryonal Carcinomas.
The staining pattern is typically membranous and cytoplasmic brown, providing valuable diagnostic information for distinguishing lymphoid neoplasms from non-hematologic tumors.

🔬 Features and Benefits CD30 Antibody

• Specific marker for Hodgkin and ALCL

• Distinct membranous/cytoplasmic brown staining

• Highly reliable for lymphoma differentiation

• Compatible with standard IHC protocols

• Excellent stability: 18-month shelf life at 2–8 °C

💡 Diagnostic Applications

• Detection of Classical Hodgkin Lymphoma (CHL)

• Identification of Anaplastic Large Cell Lymphoma (ALCL)

• Diagnosis of Primary Cutaneous CD30+ T-cell LPDs

• Evaluation of Embryonal Carcinoma

• Differentiation from Carcinoma and Melanoma

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of Talent Biomedical in Iran, provides advanced immunohistochemistry antibodies, including CD30.
With dedication to scientific excellence, global quality, and diagnostic precision, the company supports pathology laboratories and molecular diagnostic centers throughout Iran.

“Download Brochure”